Study S001808

A Study to Evaluate the Effect of LY2189265 on Gastric Emptying Using Scintigraphy in Patients With Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01215968
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 38
Start: 2010-09
Primary completion: 2011-07
Lead sponsor: Eli Lilly and Company
Conditions: Diabetes Mellitus, Type 2
Interventions: BIOLOGICAL:LY2189265; DRUG:Placebo
Results posted: TRUE
Secondary identifiers: EUDRACT_NUMBER:2009-017305-11; OTHER:H9X-EW-GBDM; NIH:2009

Registered primary outcomes

Time Required for 50% of Radioactivity To Be Emptied From the Stomach by Scintigraphy [Days 3, 10,17, 24 and 31]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.